David A. Siegel Amphastar Pharmaceuticals, Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 125,900 shares of AMPH stock, worth $5.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
125,900
Previous 127,400
1.18%
Holding current value
$5.04 Million
Previous $7.88 Million
29.84%
% of portfolio
0.01%
Previous 0.02%
Shares
24 transactions
Others Institutions Holding AMPH
# of Institutions
276Shares Held
33.4MCall Options Held
56.6KPut Options Held
57.3K-
Black Rock Inc. New York, NY6.08MShares$243 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$109 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.08MShares$83.1 Million0.21% of portfolio
-
Neuberger Berman Group LLC New York, NY1.66MShares$66.4 Million0.06% of portfolio
-
State Street Corp Boston, MA1.51MShares$60.6 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.96B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...